Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results.
about
Alogliptin benzoate for management of type 2 diabetesA Model-Based Meta-analysis to Compare Efficacy and Tolerability of Tramadol and Tapentadol for the Treatment of Chronic Non-Malignant Pain.Clinical Trial Simulation to Inform Phase 2: Comparison of Concentrated vs. Distributed First-in-Patient Study Designs in Psoriasis.A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus.Prediction of the effect on antihyperglycaemic action of sitagliptin by plasma active form glucagon-like peptide-1.Dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes treated with saxagliptin, sitagliptin, or vildagliptinDipeptidyl peptidase-4 inhibitors: pharmacokinetics, efficacy, tolerability and safety in renal impairment.Ethnic Difference in the Pharmacodynamics-efficacy Relationship of Dipeptidyl Peptidase-4 Inhibitors Between Japanese and non-Japanese Patients: A Systematic Review.Quantitative analysis of efficacy and associated factors of calcium intake on bone mineral density in postmenopausal women.Utilization of model-based meta-analysis to delineate the net efficacy of taspoglutide from the response of placebo in clinical trials.Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development.Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines.A review of methods for comparing treatments evaluated in studies that form disconnected networks of evidence.Many Flavors of Model-Based Meta-Analysis: Part II - Modeling Summary Level Longitudinal Responses.
P2860
Q28083933-FF3CA9A6-44D9-42A5-B471-1851D36B4684Q30487222-BCA715CB-7C0C-49DA-AEFA-92C766406CC8Q30542069-83F28257-D117-482F-8488-62CBE6566958Q36730226-7D4ADB19-6F11-428B-8442-1AA9D9046D99Q37008619-0CC9499A-1171-4027-A663-E2D7539F5406Q37468406-EF0E1E20-6A08-4286-B9A5-65D1026B2393Q38200670-9E6574DA-BC71-4723-9545-CD0690137AADQ38853658-05DDA90A-BC61-4E8A-B12D-38EB76CB6AD3Q38880620-2346F3A6-1884-4600-8D26-547AB4DBD002Q40803439-E5D489CE-E2E0-47BB-84FE-C52D70255DC8Q43634789-0DDBCA32-9E6C-45A8-92C1-A488C18428BEQ46800255-4C274452-9CCF-4D55-B16F-F579853E15D7Q47182659-06E6CB7E-AFDC-4FB1-8A64-8DEE23D894D2Q47712691-7ADC63FF-4531-4C87-AE95-5C8B17EC62BAQ54942333-AB30E973-B114-4976-82DB-A6D831A7C76B
P2860
Quantitative model of the relationship between dipeptidyl peptidase-4 (DPP-4) inhibition and response: meta-analysis of alogliptin, saxagliptin, sitagliptin, and vildagliptin efficacy results.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Quantitative model of the rela ...... vildagliptin efficacy results.
@en
Quantitative model of the rela ...... vildagliptin efficacy results.
@nl
type
label
Quantitative model of the rela ...... vildagliptin efficacy results.
@en
Quantitative model of the rela ...... vildagliptin efficacy results.
@nl
prefLabel
Quantitative model of the rela ...... vildagliptin efficacy results.
@en
Quantitative model of the rela ...... vildagliptin efficacy results.
@nl
P2093
P2860
P356
P1476
Quantitative model of the rela ...... vildagliptin efficacy results.
@en
P2093
Brian Smith
Itzela Correa
Jill Fredrickson
John P Gibbs
Megan A Gibbs
Shao-Lee Lin
Todd Barbee
P2860
P304
P356
10.1177/0091270011420153
P577
2011-12-12T00:00:00Z